Shuttle Pharmaceuticals Files 8-K on Agreements and Personnel Changes
Ticker: SHPH · Form: 8-K · Filed: Feb 28, 2025 · CIK: 1757499
| Field | Detail |
|---|---|
| Company | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) |
| Form Type | 8-K |
| Filed Date | Feb 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, financial-obligation, personnel-change
TL;DR
Shuttle Pharma 8-K: New deals, debt, and exec changes filed Feb 28.
AI Summary
Shuttle Pharmaceuticals Holdings, Inc. filed an 8-K on February 28, 2025, reporting on several key events. These include entering into a material definitive agreement, creating a direct financial obligation, and changes in directors and officers, including compensatory arrangements. The filing also covers financial statements and exhibits.
Why It Matters
This 8-K filing signals significant corporate actions, including new financial obligations and potential shifts in leadership or compensation, which could impact the company's strategic direction and investor outlook.
Risk Assessment
Risk Level: medium — The filing details material definitive agreements and financial obligations, which inherently carry risk, alongside changes in corporate governance.
Key Players & Entities
- Shuttle Pharmaceuticals Holdings, Inc. (company) — Registrant
- February 28, 2025 (date) — Date of earliest event reported
FAQ
What type of material definitive agreement did Shuttle Pharmaceuticals enter into?
The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in this summary.
What is the nature of the direct financial obligation created by the registrant?
The filing states that a direct financial obligation or an obligation under an off-balance sheet arrangement has been created, but the specifics are not detailed here.
What specific changes occurred regarding directors or officers?
The 8-K reports on the departure of directors or certain officers, the election of directors, and the appointment of certain officers, as well as compensatory arrangements.
When was this 8-K report filed?
The report was filed as of February 28, 2025.
What is Shuttle Pharmaceuticals Holdings, Inc.'s Standard Industrial Classification (SIC) code?
Shuttle Pharmaceuticals Holdings, Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 28, 2025 regarding Shuttle Pharmaceuticals Holdings, Inc. (SHPH).